Of course, having access to medication that people need is of utmost importance to us all, especially new medications that many of us hear about, sometimes for the first time, through constituents who may have rare diseases.
We're working with the pharmaceutical agencies on guidelines. We're engaging with them. We're receiving their feedback, and we're benchmarking with other countries.
It's important that we get the balance right and that we work with drug companies, but also that we have a focus on keeping medication affordable in Canada. We'll continue to do that work.